<?xml version="1.0"?><?xml-stylesheet type="text/xsl" href="../../web/xslt/drug-table.xslt"?><drug name = "DAUNOrubicin inj VIAL">
<dose><value>30 - 60</value>
<value>60 - 150</value>
<value>90</value>
<value>45</value>
<value>25 - 45</value>
</dose><route><value>IV</value>
</route><form><value>inj VIAL</value>
</form><drugname><value>DAUNOrubicin inj VIAL</value>
</drugname><strength><value>20 mg</value>
</strength><frequency><value>DAILY</value>
<value>ONCE</value>
</frequency><instruction><value>for 3 days.</value>
<value></value>
</instruction><volume><value></value>
</volume><units><value>mg/m2</value>
</units><additionalnotes><value>In patients with CrCl less than 10 mL/minute, adjust to 75% of normal dose. In patients with Bilirubin levels 26 to 51 umol/L administer 75% of dose, if Bilirubin level is 52 to 85 umol/L, administer 50% of dose and if Bilirubin level is greater than 80 umol/L, omit dose. MAXIMUM LIFETIME DOSES: Adult = 550 mg/m2 (normal cardiac function), 400 to 450 mg/m2 (in combination with thoracic radiation or prior anthracycline therapy). Children greater than 2 years old: 300 mg/m2 and children less than 2 years: 10 mg/m2.</value>
<value></value>
</additionalnotes><population><value>ADULT</value>
<value>CHILDREN, over 2 years of age.</value>
</population><indicationprn><value></value>
</indicationprn><backgroundinformation><value>http://intraweb01.albertahealthservices.ca/Pharmacy/AHS_FORMULARY/search_details.aspx?id=3375</value>
</backgroundinformation><prninformation><value></value>
</prninformation><ahsformularystatus><value>Formulary.</value>
</ahsformularystatus><ahfsname><value>Antineoplastic Agents</value>
</ahfsname><highalert><value>YES</value>
</highalert><maximumprndose><value>YES</value>
</maximumprndose></drug>